ArthroCare Receives FDA Clearance For Spartan 5.5 Needled Suture Implant
ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Spartan 5.5 Needled Anchor (Spartan ). Spartan is a preloaded threaded anchor indicated for use in fixation of soft tissue to bone, such as during a rotator cuff repair. The needled ...

FDA Approves Product To Prevent Bleeding In People With Rare Genetic Defect
The U.S. Food and Drug Administration approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency. Patients with congenital Factor XIII deficiency don't make enough Factor XIII, a substance that circulates in the blood and is important for normal clotting. Without treatment, people with the condition are at risk for ...